Sage Therapeutics Inc. stock soared more than 70% Thursday to mark its biggest-ever one-day price and percentage gain, after the company reported positive results in a mid-stage trial of a treatment for severe depression that could offer doctors a new mechanism to treat the disease.
Latest posts by Market Watch (see all)
- Market Extra: Gold will continue its climb in 2018, World Gold Council predicts - December 14, 2017
- Metals Stocks: Gold climbs after Fed sticks to 3 rate hikes next year - December 14, 2017
- Barron’s: What stock-market sector looks good in 2018? Think planes, trains and automobiles - December 14, 2017